20-075 Phase I
A Phase 1 Dose Escalation and Expanded Cohort Study of P-PSMA-101 in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC) (View details on clinicaltrial.gov)
Search Cancer Clinical Trials
The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
12 results
19-618 Phase I
A Phase 1 Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and Pharmacokinetics of HPN424 in Patients with Advanced Prostate Cancer Refractory to Androgen Therapy (View details on clinicaltrial.gov)
20-435 Phase I
A Phase 1, Open-label Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral EPI-7386 in Patients with Metastatic Castration-Resistant Prostate Cancer (View details on clinicaltrial.gov)
19-060 Phase I
A Phase 1/2, open-label, dose escalation and cohort expansion clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ARV-110 in patients with metastatic castration-resistant prostate cancer (View details on clinicaltrial.gov)
18-117 Phase II
A Phase 2 Study of PCM-075 in Combination with Abiraterone and Prednisone in Subjects with Metastatic Castration-Resistant Prostate Cancer (View details on clinicaltrial.gov)
19-241 Phase III
A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer (View details on clinicaltrial.gov)
19-580 N/A
A PROSPECTIVE COMPARATIVE STUDY OF OUTCOMES WITH PROTON AND PHOTON RADIATION IN PROSTATE CANCER (COMPPARE) (View details on clinicaltrial.gov)
20-581 Phase II
An Open-Label Phase 1b Study of ORIC-101 in Combination with Enzalutamide in Patients with Metastatic Prostate Cancer Progressing on Enzalutamide (View details on clinicaltrial.gov)
08-207 N/A
Circulating Tumor Cell Analysis in Patients with Localized Prostate Cancer Undergoing Prostatectomy (View details on clinicaltrial.gov)
19-267 N/A
Continuing Access to the Tyrosine Kinase Inhibitor Of VEGFR-2, AG-013736 (A406) For Patients Previously Receiving AG-013736 In Clinical Trials (View details on clinicaltrial.gov)
Showing 1 - 10 of 12 results